Tirzepatide is available under the names Mounjaro and Zepbound in the U.S.: Mounjaro FDAapproved since May 2022 for type 2 diabetes management
They slow down digestion
What clinicians consider when advising against GLP-1 use during breastfeeding Lack of large, controlled lactation safety trials Unknown effects on infant growth or neurodevelopment Uncertainty about effects on milk supply or composition Elective nature of GLP-1 therapy for weight loss Availability of safer alternatives after breastfeeding ends Why FDA and medical guidance remains cautious FDA and specialty guidance emphasize caution during breastfeeding for several consistent reasons: Insufficient data: FDA labeling states there are inadequate data on GLP-1 medication effects in breastfed infants.,, Milk supply unknowns: It is not known whether GLP-1 medications affect milk supply (volume) or milk composition., Infant vulnerability: Early infancy is a sensitive developmental period, increasing caution when medication effects are unknown. Elective vs essential use: For weight management, potential maternal benefit often does not outweigh theoretical infant risk.,, Do semaglutide and tirzepatide pass into breast milk
After many hours of an exhausting labor, you welcome a new tiny human into the world and embrace them in your arms
Consistent use supports your skin health, immune function, and overall well-being
The seven tips shared like picking a regular day and time, tying injections to daily habits, setting reminders, planning around side effects, managing missed doses, staying stocked with supplies, and perfecting your technique address common hurdles and make it easier to stay on track
